Reparixin L-lysine salt
Cat. No.：YN320951
CAS No. ：266359-93-7
| 产品名称: | Reparixin L-lysine salt |
| CAS No.: | 266359-93-7 |
| Chemical Name: | (αR)-α-methyl-4-(2-methylpropyl)-N-(methylsulfonyl)benzeneacetamide, L-lysine |
| Synonyms: | Repertaxin L-lysine salt |
| 分子量: | 429.57 |
| 分子式: | C₂₀H₃₅N₃O₅S |
| SMILES: | N[C@@H](CCCCN)C(O)=O.CS(=O)(NC([C@@H](C1=CC=C(CC(C)C)C=C1)C)=O)=O |
| 存储: | Please store the product under the recommended conditions in theCertificate of Analysis. |
| 运输: | Room temperature in continental US; may vary elsewhere. |
| 产品描述: | Reparixin L-lysine salt是趋化因子受体1/2 (CXCR1/2)活化的变构抑制剂。 |
| IC50和靶点: | [{name:"CXCR1wt:5.6 nM (IC50, in L1.2 cells)"},{name: "CXCR1Ile43Val:80 nM (IC50, in L1.2 cells)"},{name: "CXCR1:1 nM (IC50, in cells)"},{name: "CXCR2:∼100 nM (IC50, in cells)"}] |
| In Vitro: | |
| In Vivo: | |
| Clinical Trial: | |
| Solvent & Solubility: |
Bertini, R., Allegretti, M., Bizzarri, C., et al.Noncompetitive allosteric inhibitors of the inflammatory chemokine receptors CXCR1 and CXCR2: Prevention of reperfusion injuryProc. Natl. Acad. Sci. USA101(32),11791-11796(2004)
Kim, H.Y., Choi, J.H., Kang, Y.J., et al.Reparixin, an inhibitor of CXCR1 and CXCR2 receptor activation, attenuates blood pressure and hypertension-related mediators expression in spontaneously hypertensive ratsBiol. Pharm. Bull.34(1),120-127(2011)
Ginestier, C., Liu, S., Diebel, M.E., et al.CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenograftsJ. Clin. Invest.120(2),485-497(2010)
